INTRODUCTION {#s1}
============

The coronavirus disease 2019 (COVID-19) is a viral infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a member of the β-coronavirus cluster of enveloped single-stranded RNA viruses. This novel viral infection first presented as a series of unexplained cases of pneumonia in Wuhan, China in December of 2019.^[@r1],[@r2]^ The virus spread rapidly, predominantly through person-to-person transmission via respiratory droplets or direct contact, and was declared a pandemic by the World Health Organization on March 11, 2020.^[@r3]^ As of April 13, 2020, there have been 1,773,084 confirmed cases of COVID-19 and 111,652 deaths across over 200 countries and territories worldwide. In the United States, there have been 524,514 confirmed cases and 20,444 reported deaths.^[@r4]^

Although COVID-19 predominantly affects the adult population, recently there have been increasing reports in the media of infected pediatric patients and young adults; especially in the United States of America. Furthermore, although pediatric patients are more likely to have a milder clinical course, they are just as likely as adults to become infected and thus play an important role in ongoing disease transmission.^[@r5],[@r6]^ Unfortunately, despite increasingly reported pediatric cases and their potential role in disease spread, the published literature for pediatric COVID-19 infections is limited; particularly as pertains to imaging manifestations of pediatric COVID-19 pneumonia. However, within the currently available scarce literature, there are differences emerging in imaging features between pediatric and adult cases of COVID-19 pneumonia of which both radiologists and referring physicians should be aware.

Given the non-specific clinical presentation of coronavirus 2019, imaging studies are likely to play an important role in diagnostic work-up for affected pediatric patients. The lack of published information can lead to unease and diagnostic uncertainty for pediatric and general radiologists both in identifying findings suggestive of COVID-19 and in determining appropriate use of imaging for the pediatric population with suspected COVID-19 infection. As the pandemic continues to flourish, practical guidance is needed to address both of these concerns for practicing radiologists and referring physicians.

Therefore, the goal of this study is to generate a consensus statement for chest imaging in pediatric patients with COVID-19 infection by international experts from 5 continents. Existing literature and clinical experience amongst the expert panel was utilized to describe imaging manifestations of COVID-19 in the pediatric population, discuss the potential utility of structured reporting during the coronavirus 2019 pandemic, and report consensus recommendations for utilization of chest radiographs (CXR) and computed tomography (CT) in evaluation of COVID-19.

METHODS {#s2}
=======

This consensus statement is based on expert opinions from 6 pediatric thoracic radiologists from 6 countries across 5 continents from the United States, Spain, Hong Kong, Brazil, South Africa, and United Emirates. They are current active members of the Society for Pediatric Radiology (SPR), the European Society of Paediatric Radiology (ESPR), the Asian and Oceanic Society for Pediatric Radiology (AOSPR), the Sociedad Latino Americana de Radiologica Pediatrica (SLAPR), the South African Society of Pediatric Imaging (SASPI), and the Radiology Society of the Emirates (RSE), respectively. Several members of the panel have experience with managing pediatric patients during the current pandemic, as well as prior pandemics including Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Swine-Origin Influenza A (H1N1).^[@r7]--[@r14]^ The panel met via a single live audio and video conference call to discuss chest imaging findings and recommendations. Standardized reporting recommendations grouping CXR and CT findings into 4 diagnostic categories were also discussed until consensus was achieved.

The final document is supported by an extensive literature review utilizing the search terms "((COVID-19 OR Coronavirus 2019 OR SARS-CoV2 OR nCoV) AND (pediatric OR children) AND (radiology OR imaging OR CT OR computed tomography OR CXR))" which revealed 46 related articles in the English literature. These articles were reviewed for content and 8 articles with sufficient pediatric COVID-19 pneumonia related imaging data were used to generate a summary of imaging findings. The IRB waived informed consent as all imaging studies reviewed were obtained as part of routine patient care and patient risk is minimal. New images from two previously reported patients (*American Journal of Roentgenology* article in press), which are different than the images used in that paper, are included in this paper for illustrative purposes rather than the imaging data analyzed for the original research.^[@r14]^

IMAGING IN PEDIATRIC PATIENTS WITH COVID-19 {#s3}
===========================================

The role of radiologic examinations in initial diagnosis, evaluation of disease progression, and prognostication is currently an area of active research and discussion among the medical community. Multiple factors including sensitivity and specificity of radiological examinations, availability and accuracy of RT-PCR tests, and radiation dose considerations all should be considered when making decisions regarding imaging in pediatric patients with suspected COVID-19 infection. Ultimately, many pediatric patients will undergo some level of imaging evaluation and thus an understanding of imaging findings in COVID-19 is essential for practicing general and pediatric radiologists.

CONSIDERATIONS FOR STANDARDIZED REPORTING OF IMAGING FINDINGS FOR COVID-19 IN PEDIATRIC PATIENTS {#s4}
================================================================================================

Given the rapid onset of the COVID-19 pandemic, the continually evolving understanding of the imaging manifestations of the disease, and the implications of the diagnosis for both patients and providers, many radiologists feel hesitant about when or if to specify COVID-19 pneumonia in the differential diagnosis. Structured reporting may help address this concern by creating defined categories for imaging findings and standard language that can lead to improved understanding between the radiologist and ordering provider. Utilization of structured radiology reports has been shown to improve recall and decrease incorrect diagnoses by referring physicians compared to unstructured reports.^[@r15]^ Furthermore, structured reporting may offer additional potential benefits such as improved reporting of key imaging features and increased confidence and clarity of terminology use by the radiologist.^[@r16],[@r17]^

There are a few limitations of structured reporting for COVID-19 that merit mention. First, the utilization of a COVID-19 structured template will be best employed in regions where there is a high prevalence of the disease. There is some overlap in the imaging presentation of COVID-19 and other entities, including infections (Influenza A, Influenza B, or Mycoplasma Pneumonia), inflammatory processes (e-cigarette vaping associated lung injury (EVALI) or hypersensitivity pneumonitis (HP)), and eosinophilic lung disease in the pediatric population, and therefore a low COVID-19 prevalence could lead to false positive results.^[@r13],[@r14],[@r18]--[@r24]^ Second, introducing the term COVID-19 pneumonia into the patient's clinical record may cause ordering physicians to feel constrained in future clinical decision making. Open and careful discussion with the referring doctor concerning the level of clinical suspicion for COVID-19 should help mitigate these issues. In some cases, following discussion with the clinical team, it may be appropriate to utilize more broad terms such as "viral or atypical pneumonia" depending on the clinical picture.

Ultimately, the decision to pursue standardized reporting for pediatric COVID-19 pneumonia will depend on individual practice patterns, as well as disease incidence within the practice location, and is likely best achieved through discussion between radiologists and referring providers. This study provides recommendations of what structured vocabulary would look like for groups who choose to pursue this option.

CHEST RADIOGRAPHY {#s5}
=================

Imaging Findings of COVID-19 on CXR in Pediatric Patients
---------------------------------------------------------

Although CXR are frequently the first imaging study in the evaluation of a pediatric patient presenting with fever, cough, and/or shortness of breath, the current literature describing COVID-19 findings on CXR is relatively scare. The limited data available suggests that CXR, at least in adults, is less sensitive than CT for identifying imaging findings associated with COVID-19. In one study of nine COVID-19 positive adults, chest radiographs showed bilateral patchy consolidation with associated ground glass opacity in a peripheral and lower lung zone predominant pattern in 3/9 (33.3%) cases while chest CT demonstrated lung parenchymal abnormality in 8/9 (88.9%) cases.^[@r25]^ In a follow-up study, which included the aforementioned 9 patients plus 8 additional adult cases, CXR had a median sensitivity, among 8 thoracic radiologists, of 25% (interquartile range \[IQR\], 20-26.3%) and median specificity of 90% (IQR, 88.8-96.3%) for identifying lung opacities identified on same day chest CT.^[@r26]^ Ng et al reported normal CXRs in 2/5 (40%) and ground glass opacities in 3/5 (60%) adult patients with COVID-19, although all 5/5 (100%) patients were found to have peripheral predominant ground glass opacities on CT.^[@r27]^ Sequential CXR in the 3 radiographically positive cases showed initial progression of lung consolidation followed by improvement in 2/3 (66.7%) patients and no change in 1/3 (33.3%) suggesting radiography may be helpful in evaluating disease progression/resolution.^[@r27]^

Published data of CXR findings of COVID-19 pneumonia is even more scarce in the pediatric population, although one case series with 10 pediatric patients observed unilateral patchy opacities in 4/10 (40%) cases.^[@r28]^ In the clinical experience of this expert panel of pediatric chest radiologists, both unilateral and bilateral opacities have been observed in pediatric COVID-19, although bilateral opacities are more typical **([Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"})**. CXR is perhaps even more essential in this patient population due to increased radiation sensitivity of children and hesitancy to pursue cross-sectional imaging such as CT, thus continued investigation and reporting of observed pediatric CXR abnormalities in COVID-19 is imperative.

![16-year-old female with tuberous sclerosis and positive COVID-19 RT-PCR test who presented with acute hypoxic respiratory distress. Frontal chest radiograph shows bilateral lower lung zone-predominant consolidation and ground-glass opacities, which is typical CXR findings of pediatric COVID-19 pneumonia. Also noted are endotracheal tube and nasogastric tube.](ryct.2020200214.fig1){#fig1}

![15-year-old female with asthma and positive COVID-19 RT-PCR test who presented with fever and respiratory distress. Frontal chest radiograph shows ground-glass opacities in both peripheral (asterisk) and central (arrow) distribution, which are indeterminate CXR findings of pediatric COVID-19 pneumonia. Also noted is right apical pneumothorax.](ryct.2020200214.fig2){#fig2}

Current Recommendations for CXR in Pediatric Patients with Suspected or Known COVID-19
--------------------------------------------------------------------------------------

Based on very limited data, CXRs may show patchy opacities with peripheral and lower lung zone predominance; however, they are less sensitive than CT for detecting parenchymal abnormalities in pediatric patients COVID-19. According to the American College of Radiology (ACR) appropriate criteria, imaging is not indicated in a well appearing immunocompetent child ≥ 3 months of age who does not require hospitalization. However, if the child is not responding to outpatient management, requires hospitalization, or is suspected of having hospital acquired pneumonia, CXR is considered the most appropriate first step in imaging evaluation.^[@r29]^ Thus, as with other viral pulmonary infections, initial chest radiographs are not indicated in pediatric patients with mild symptoms, but should be considered in pediatric patients with suspected COVID-19 presenting with moderate to severe acute respiratory illness symptoms. However, due to limited sensitivity and specificity, a negative CXR does not exclude pulmonary involvement in patients with laboratory confirmed COVID-19 nor does it indicate absence of COVID-19 infection in cases of suspected COVID-19 infection not yet confirmed by RT-PCR.

Serial CXRs to assess response to supportive treatment and/or disease progression may be beneficial in pediatric COVID-19 patients with positive findings on initial CXR and/or in cases of clinical deterioration.

Structured CXR Reporting Recommendations in Pediatric Patients with Suspected or Known COVID-19
-----------------------------------------------------------------------------------------------

Suggested structured reporting for CXR findings for pediatric patients undergoing workup for COVID-19 pneumonia divides imaging manifestations into 4 distinct categories: typical, indeterminate, atypical, and negative. Given the extremely limited pediatric data for CXR findings in COVID-19 pneumonia, recommendations are based on a combination of patterns observed in adult literature and observational experience of the expert panel at the time of meeting (**[Table 1](#tbl1){ref-type="table"}**). These recommendations may evolve as understanding of COVID-19 continues to improve.

###### 

Structured CXR Reporting for Pediatric COVID-19

![](ryct.2020200214.tbl1)

### Typical CXR Finding Classification

The typical CXR finding classification is used to denote the imaging pattern most suggestive of COVID-19 pneumonia; namely bilateral peripheral and/or subpleural ground-glass opacities and/or consolidation **([Figure 1](#fig1){ref-type="fig"})**. Structured report language for this group should reflect that the CXR imaging pattern is commonly seen in children with COVID-19 pneumonia, however other viral or atypical pneumonia would also be differential considerations.

### Indeterminate CXR Finding Classification

The indeterminate CXR finding classification includes imaging findings that have been observed in COVID-19 pneumonia, but are less specific than those of the typical group such as unilateral non-segmental/lobar ground-glass or consolidative opacities or multifocal groundglass/consolidative opacities without any particular distribution **([Figure 2](#fig2){ref-type="fig"})**. Features typical of viral pneumonia and reactive small airways disease, such as peribronchial thickening and/or opacities, are also included in this group, and have been observed more frequently in pediatric COVID-19 pneumonia cases than in adults.^[@r30]^

### Atypical CXR Finding Classification

The atypical CXR finding classification is reserved for the CXR imaging findings which are infrequently observed in COVID-19 pneumonia and suggest that an alternative diagnosis should be considered. CXR findings for this group include unilateral segmental or lobar consolidation suggestive of bacterial pneumonia **([Figure 3](#fig3){ref-type="fig"})**, a central distribution of parenchymal opacities, a single round consolidation (i.e., round pneumonia with or without air bronchogram) **([Figure 4](#fig4){ref-type="fig"})**, pleural effusion, and lymphadenopathy.

![9-year-old female with renal transplant and positive COVID-19 RT-PCR test who presented with respiratory distress. Frontal chest radiograph shows consolidation (asterisk) in the left lower lobe, which is atypical for pediatric COVID-19 pneumonia.](ryct.2020200214.fig3){#fig3}

![4-year-old male with fever and respiratory distress. Frontal chest radiograph shows a round consolidation (arrow) in the medial right upper lung zone which is atypical for pediatric COVID-19 pneumonia. This patient's round pneumonia was due to bacterial infection.](ryct.2020200214.fig4){#fig4}

### Negative CXR Finding Classification

Finally, the negative CXR finding classification is used to describe a CXR with no evidence of pneumonia. However, given the limited sensitivity of CXR for detection of COVID-19 pneumonia, a statement to this effect may be included in the structured language for this category.

CHEST COMPUTED TOMOGRAPHY {#s6}
=========================

Imaging Findings of COVID-19 on Chest CT in Pediatric Patients
--------------------------------------------------------------

The chest CT findings observed in COVID-19, most commonly described as bilateral multifocal peripheral and/or subpleural ground glass opacities, often in a posterior and/or lower lobe predominant distribution, with or without consolidation, have mainly been described in the adult literature.^[@r31]--[@r40]^ Although the imaging literature in pediatric patients is less robust, overall pediatric patients tend to demonstrate milder imaging findings compared to adults. A study evaluating CT findings in 98 COVID-19 positive patients across multiple age groups found that pediatric patients (\< 18 years old) had a lower total number of pulmonary lesions and smaller size of pulmonary lesions compared with adults.^[@r41]^ Similarly, a comparison study of CT findings in 14 pediatric patients compared with 47 adults, all with RT-PCR confirmed COVID-19 infections, found that the pediatric patients had significantly lower rate of positive CT findings, lower number of pulmonary lobes involved and lower overall semi-quantitative lung score.^[@r30]^

In pediatric patients with abnormalities found on CT, the most common findings are bilateral peripheral and/or subpleural ground-glass and/or consolidative opacities often in the lower lobes of the lungs **([Figure 5](#fig5){ref-type="fig"})**.^[@r30],[@r42]--[@r45]^ The "halo" sign, which describes a focal consolidation with a rim of surrounding ground-glass opacity, has been reported in up to 50% (10/20) of cases and can help narrow the differential diagnosis when present.^[@r45]^ Based on the experience of this expert panel, three phases of evolution have been observed in pediatric COVID-19 cases demonstrating the "halo" sign: the "halo" sign is generally observed early in the disease course (early phase) and progresses to ground-glass (progressive phase) and eventually develops into consolidative opacities (developed phase) **([Figure 6](#fig6){ref-type="fig"})**. Peribronchial thickening and inflammation along the bronchovascular bundle are observed more frequently in the pediatric population compared to adults.^[@r30]^ Fine mesh reticulations and "crazy paving" sign have also been reported, although with less frequency across the literature.^[@r45],[@r46]^ Pleural effusion and lymphadenopathy are rare.^[@r30],[@r45]^

![A 21-month-old female with Hurler's disease status post bone marrow transplant and positive COVID-19 RT-PCR test who presented with fever and respiratory distress. Axial lung window CT image shows bilateral peripheral and subpleural ground-glass opacities, which are typical CT findings in pediatric COVID-19.](ryct.2020200214.fig5){#fig5}

![Three different phases (early, progressive, and developed) of COVID-19 pneumonia in three different pediatric patients. A. Early phase of pediatric COVID-19 pneumonia in a 14year-old female with Hodgkin's lymphoma and positive COVID-19 RT-PCR test who presented with fever and cough. Axial lung window CT image shows a rounded ground-glass opacity (arrow) with subtle area of central consolidation in keeping with the "halo" sign which is often seen in early phase of pediatric COVID-19 pneumonia. B. Progressive phase of pediatric COVID-19 pneumonia in a 15-year-old female with traveling history in endemic area in Europe and positive COVID-19 RT-PCR test who presented with increasing cough and shortness of breath. Axial lung window CT image demonstrates rounded ground glass opacities (arrows) with subtle area of central consolidation. Between these areas, ground-glass opacities (asterisks) start to fill the lung parenchyma. C. Developed phase of pediatric COVID-19 pneumonia in a 16year-old female with positive COVID-19 RT-PCR test who presented with severe shortness of breath. Axial lung window CT image shows predominantly confluent consolidation (arrow) in the posterior left lower lobe.](ryct.2020200214.fig6){#fig6}

Data regarding chest CT findings of subacute COVID-19 infection in pediatric patients is limited. In one study with six pediatric patients who underwent follow up CT within 0.5-2 weeks of presentation, 2 (33.3%) demonstrated complete resolution of pneumonia, 3 (50%) demonstrated partial resolution of consolidation, and 3 (50%) patients demonstrated a residual fibrous strip.^[@r45]^

Current Recommendations for Chest CT in Pediatric Patients with Suspected or Known COVID-19
-------------------------------------------------------------------------------------------

Although the chest CT findings of COVID-19 in the pediatric population are not pathognomonic, a bilateral peripheral subpleural lower lobe predominant pattern of ground-glass opacities is suggestive of the diagnosis in the appropriate clinical setting. However, RT-PCR is considered the gold standard for diagnosis of COVID-19 pneumonia as it has been shown to have comparable (high COVID-19 prevalence areas) to superior sensitivity (low prevalence COVID-19 areas) and overall better specificity compared to chest CT.^[@r47]^ Thus the American College of Radiology currently recommends against using CT as a first line screening test to diagnose COVID-19 and states that chest CT should be reserved for symptomatic hospitalized patients with specific clinical indications.^[@r48]^

Chest CT is not recommended as the initial diagnostic test in pediatric patients with suspected COVID-19. However, it may be considered to answer a specific clinical question in the acute setting (for example to exclude a pulmonary embolism in a patient with an elevated Ddimer level). Additionally, chest CT may be considered in pediatric COVID-19 patients with a worsening clinical course and/or who are not responding appropriately to supportive therapy. Finally, follow-up chest CT may be helpful to assess for development and/or evolution of fibrotic lung disease in patients with persistent alterations in PFTs following resolution of the acute infection. For all pediatric patients in whom chest CT is being entertained, additional factors including contamination of the CT scanner room (which may require subsequent room down time for air exchange and cleaning) and radiation dose are important to keep in mind.

Structured CT Reporting Recommendations for Pediatric Patients with Suspected or Known COVID-19
-----------------------------------------------------------------------------------------------

The recommended structured reporting for pediatric chest CT evaluation in cases of suspected COVID-19 pneumonia is divided into the same four categories described in the CXR section of this paper above (typical, indeterminate, atypical, and negative) and adapted from the structured CT reporting for adult COVID-19 patients **([Figures 5](#fig5){ref-type="fig"}-[10](#fig10){ref-type="fig"}).**^[@r17]^ CT findings for each category in this group are based on imaging patterns observed in pediatric studies across the literature as well as the experience of the international pediatric thoracic radiologists involved in this consensus statement. The summary of the imaging findings and suggested structured CT reporting for each category are shown in **[Table 2](#tbl2){ref-type="table"}**.

![16-year-old female with positive COVID-19 RT-PCR test who presented with shortness of breath. Axial lung window CT image shows ground-glass opacity with small component of consolidation in the posterior left lower lobe, which are indeterminate CT findings of pediatric COVID-19 pneumonia.](ryct.2020200214.fig7){#fig7}

![16-year-old female who presented with fever, cough and chest pain. Axial lung window CT image shows bilateral central consolidation and ground-glass opacities, which are atypical CT findings of pediatric COVID-19 pneumonia. This patient's CT findings are due to biopsy proven varicella pneumonia.](ryct.2020200214.fig8){#fig8}

![8-year-old girl who presented with fever and worsening cough. Axial lung window CT image shows bilateral discrete small nodules in tree-in-bud pattern in right middle lobe and lingula which are atypical CT findings for pediatric COVID-19 pneumonia. This patient's CT findings are due to mycobacterium infection.](ryct.2020200214.fig9){#fig9}

![16-year-old female with who presented with fever and cough. Axial lung window CT image shows a peripherally located lung lesion with cavitation in the right lower lobe, which are atypical CT findings for pediatric COVID-19 pneumonia. This patient's CT findings are due to Staphylococcus aureus infection.](ryct.2020200214.fig10){#fig10}

###### 

Structured CT Reporting for Pediatric COVID-19

![](ryct.2020200214.tbl2)

IMAGING RECOMMENDATIONS BASED ON CLINCIAL INDICATIONS {#s7}
=====================================================

Imaging recommendations are described for pediatric patients in 3 distinct clinical situations at the time of initial presentation, similar to the recent Fleischner Society consensus statement for adult patients.^[@r49]^ (**[Table 3](#tbl3){ref-type="table"}**) These situations include pediatric patients presenting with mild clinical features of COVID-19, with moderate-to-severe clinical features of COVID-19 in a without resource constrained environment, and with moderate-to-severe clinical features of COVID-19 in a resource constrained environment. Additional recommendations are described for situations involving sequential studies and post-recovery follow-up imaging.

###### 

Definitions for Terms Described in Clinical Situations

![](ryct.2020200214.tbl3)

There are potential risks of imaging that include a potentially non-diagnostic study, radiation exposure, COVID-19 exposure to radiology staff, and increased imaging equipment/room turnaround time for appropriate cleaning and air turnover. These risks must be weighed against the potential benefits of imaging, such as informed decision making regarding patient triage and isolation, establishing baseline imaging, and identification of alternative diagnosis or comorbid conditions when deciding to pursue CXR or chest CT in the pediatric population. Additional factors, including the prevalence of COVID-19 in the local population, travel history to a high COVID-19 prevalence area, and the presence of comorbid medical conditions that could increase the risk of disease progression/severity (such as asthma, cystic fibrosis, congenital heart disease, chronic lung disease of prematurity (also known as bronchopulmonary dysplasia), malignancy, chronic infection (e.g., tuberculosis or HIV) and/or immunosuppressed state as may be observed in pediatric patients with bone marrow or other visceral transplants) should also play a role in imaging decisions.

Situation 1: Mild Clinical Features of COVID-19 in Pediatric Patients
---------------------------------------------------------------------

Pediatric patients in this group often present in the outpatient setting with mild clinical symptoms such as fever, cough, and/or rhinorrhea. In this situation, COVID-19 testing with RTPCR should be the first step in screening evaluation. If COVID-19 testing is not readily available, these pediatric patients can be stratified into a suspected COVID-19 positive group in endemic areas with known community spread and suspected negative in locations with low disease prevalence. Given the overall milder clinical course of COVID-19 in the pediatric population and the increased radiation sensitivity of pediatric patients, imaging is not recommended for the majority of patients in the mild group at the time of presentation regardless of RT-PCR results. However, for patients with positive COVID-19 status (either by laboratory diagnosis or presumed positive status based on local disease prevalence) who have underlying comorbidities (i.e. asthma, cystic fibrosis, congenital heart disease, malignancy, bronchopulmonary dysplasia, chronic infections (e.g. tuberculosis or HIV) and/or immunosuppressed state) placing them at risk for disease progression, chest imaging is recommended to serve as a baseline as well as to evaluate for alternative diagnoses possibly related to a comorbid condition (for example pulmonary edema in congenital heart disease). Even in pediatric patients with elevated risk for progression, chest CT is not recommended at the time of presentation for diagnosis of COVID-19, but may be considered in cases of clinical progression, inadequate clinical improvement, or when an alternative diagnosis (such as concern for pulmonary embolism) necessitates further evaluation. Regardless of underlying clinical risk factors or COVID-19 disease status, worsening respiratory function in a pediatric patient initially considered to have mild clinical features is an indication for further evaluation with chest imaging.

Situation 2: Moderate-to-Severe Clinical Features of COVID-19 in Pediatric Patients in a Without Resource Constrained Environment
---------------------------------------------------------------------------------------------------------------------------------

Pediatric patients with suspected COVID-19 in this group present with clinical signs of more serious respiratory compromise, including moderate to severe dyspnea or hypoxemia, or symptoms such as chest pain, tachycardia, hypotension, or altered mentation that may indicate cardiovascular compromise and/or pending shock. COVID-19 testing with RT-PCR is the initial screening test recommended for this group without resource constraints. If testing or timely results are not readily available, these patients can be further classified into presumed positive or presumed negative COVID-19 status based on local disease prevalence. Regardless of COVID-19 status, CXR is recommended for initial evaluation of the pediatric patient presenting with moderate to severe clinical features to establish an imaging baseline and evaluate for alternative diagnosis. Chest CT may also be considered in this group if the outcome will impact clinical decision making (i.e. imaging findings would affect how closely a patient is clinically followed and possibly followed with imaging to asses for change or potential complication), however should not serve as the screening examination to assess COVID-19 status. One important note for the moderate-to-severe group is that in pediatric patients initially categorized into the negative COVID-19 group (either by RT-PCR or low community prevalence) who are found to have imaging manifestations commonly seen in COVID-19, repeat laboratory COVID-19 testing (or initial testing if grouped based on community prevalence) is recommended.

Situation 3: Moderate-to-Severe Clinical Features of COVID-19 in Pediatric Patients in a Resource Constrained Environment
-------------------------------------------------------------------------------------------------------------------------

Situation 3 describes a plan for COVID-19 screening in an environment where laboratory testing is unavailable or lengthy turnaround time for results would preclude rapid triage decisions, potentially overwhelming a health system with limited resources (limited hospital beds, ventilators, personal protective equipment, etc.). In this specific situation, imaging may be used as an initial step to evaluate for findings suggestive of COVID-19 (presumed positive) versus findings suggestive of an alternative diagnosis. Given the limited sensitivity of CXR, chest CT, specifically tailored to low-dose technique for pediatric patients closely following the ALARA (as low as reasonable achievable) principle, may be considered for assessment of this group either initially or following unrevealing CXR.^[@r50],[@r51]^ If no alternative diagnosis is identified and imaging findings are non-specific, but extensive enough to be worrisome, the hospital will then have to make triage decisions related to concerns for COVID-19 based on overall clinical picture, local disease prevalence, and known resource limitations.

Sequential Imaging in Moderate-to-Severe Pediatric COVID-19
-----------------------------------------------------------

Sequential CXRs are appropriate in pediatric COVID-19 patients on an as clinically needed basis to monitor response to supportive measures, assess clinical deterioration, or evaluate positioning of life support devices. Similar to recommendations for the adult population, daily routine CXRs are not indicated for clinically stable, intubated pediatric ICU patients with COVID-19. Although there is less literature on the use of daily CXRs in pediatric ICU patients, one large study with over 1,500 pediatric patients showed no significant difference in average PICU length of stay, hospital length of stay, or days on ventilator support and absence of reported adverse outcomes between patients with a standing order for daily CXR versus patients with CXR ordered for a specific clinical indication.^[@r52]^

A chest CT in this group may be considered, especially if not pursued at the time of initial presentation, in pediatric patients who are not responding appropriately to supportive care or demonstrate clinical deterioration. However, given the increased radiation dose, chest CT is only recommended if it would directly impact clinical decision making in pediatric patients given their increased sensitivity to radiation compared with adults.

Post-Recovery Follow-Up Chest Imaging in Pediatric COVID-19
-----------------------------------------------------------

The decision to pursue post-treatment follow-up chest imaging should be based both on the severity of disease (mild verses moderate-to-severe) and the presence (or absence) of clinical symptoms (i.e., dyspnea, decreased exercise tolerance, etc.) at the time of follow-up. As longterm data is not yet available for pediatric COVID-19 patients, recommendations currently presented in this article are based consensus expert opinion as well as long term follow-up experience with SARS and MERS.^[@r8],[@r11]^

For asymptomatic pediatric patients who had a mild disease course, no long term imaging follow-up is recommended. However, even pediatric patients with a mild disease course may develop long standing pulmonary injury and thus a follow-up standard two-view (PA and lateral) CXR should be considered in symptomatic patients with prior mild COVID-19. Follow-up imaging in this group can evaluate for evidence of pulmonary scaring/fibrosis and also evaluate for other potentially treatable causes for the patients' symptoms.

In pediatric patients with a moderate-to-severe COVID-19 infection, a follow-up standard two-view CXR is recommended for symptomatic pediatric patients, for the same reasons as described above for symptomatic mild cases, and may be considered in asymptomatic pediatric patients depending on level of clinical concern for long-term lung injury. Long term follow-up studies of both SARS and MERS patients have demonstrated chronic pulmonary parenchymal abnormalities, including air trapping and pulmonary fibrosis, in up to approximately 1/3 (33.3%) of patients.^[@r8],[@r11]^ Therefore, a follow-up standard two-view CXR, even in asymptomatic pediatric patients, may be appropriate for this group.

CONCLUSION {#s8}
==========

The coronavirus 2019 pandemic is currently a rapidly evolving situation and has created an environment of uncertainty. The purpose of this consensus statement is to help address COVID-19 related uncertainty in pediatric patients for practicing radiologists and referring clinicians by providing up-to-date knowledge about the imaging manifestations of COVID-19 pneumonia in children, proposing a template for structured radiologic reporting in this patient population, and offering practical guidance regarding utilization of chest imaging in the pediatric patient population (**[Table 4](#tbl4){ref-type="table"}**). As knowledge about the presentation and evolution of COVID-19 pneumonia in pediatric patients continues to grow, the information and recommendations provided by this document may undergo additional refinement. Practice patterns will vary across institutions and thus this consensus statement is meant to offer guidance, however best results will likely be achieved through candid discussions between individual radiology groups and their respective referring providers.

###### 

Summary of Imaging Recommendations

![](ryct.2020200214.tbl4)
